Heart implant offers lifeline for patients who Can't take blood thinners
NCT ID NCT06465459
Summary
This study is collecting real-world data on a heart implant device called LambrE. The device is for patients with atrial fibrillation (AFib) who are at high risk of stroke but have a permanent medical reason they cannot take standard blood-thinning medications. The goal is to see how well the implant prevents strokes and other heart-related problems over time by sealing off a small pouch in the heart where clots often form.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Cardiologique de Haut Lévêque
RECRUITINGPessac, 33600, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.